Font Size: a A A
Keyword [advanced lung adenocarcinoma]
Result: 1 - 20 | Page: 1 of 7
1. Effect Of Common EGFR Mutant Genotype On Second - Line Treatment Strategy Of Advanced Lung Adenocarcinoma
2. Effectiveness Of Gefitinib As The First-line Therapy In Patients With Advanced Lung Adenocarcinoma
3. Pemetrexed And Cisplatin As First-line Chemotherapy For Advanced Lung Adenocarcinoma: An Observation Of Recent Clinical Therapeutic Effects And Safety Profile
4. Clinical Observation Pemetrexed Combined With Cisplatin As First-line Treatment Of Advanced Lung Adenocarcinoma
5. MET Expression And Gene Amplification In Advanced Lung Adenocarcinoma
6. 1.Basic And Clinical Reaearch Of Drug Resistant Genes For The Evaluation Of Chemotherapy Curative Effect In Lung Cancer 2.Subsequent Treatment Of EGRF Tyrosine Kinase Inhibitor Failure In Patients With Advanced Lung Adenocarcinoma
7. Gefitinib Concurrent With Individualized Thoracic Radiotherapy For Locally Advanced Lung Adenocarcinoma
8. The Clinical Research Of Replenishing Qi Nourishing Yin Resolving Stasis Detoxing Formula Sided With Pemetrexed Combined With Platinum Chemotherapy In The Treatment Of Advanced Adenocarcinoma Of The Lung
9. The Detecting Of Epidermal Growth Factor Receptor Gene Mutations And Observing The Efficacy Of Chemotherapy Of Advanced Lung Adenocarcinoma Patients
10. Polymorphism In The3’-untranslated Region Of Thymidylate Synthase Gene And Sensitivity Of Advanced Lung Adenocarcinoma To Pemetrexed
11. Observation Of Efficacy And Safety Of Pemetrexed Plus Nedaplatin In Chemotherapy-naive Patients With Advanced Lung Adenocarcinoma
12. Research Of First-line Treatment Of139Patients With Advanced Lung Adenocarcinoma
13. Clinical Observation On The Effect Of Lung Tumor-extract Combined Treatment Of DC-CIK Cells For Advanced Lung Adenocarcinoma And Expeirmental Study On Effect Of VEGF Secretion
14. The Application Of The Low-dose Volume Perfusion CT Follow-up Mode In Advanced Lung Adenocarcinoma Patients With EGFR-TKI Treatment Follow-up
15. Analysis Of Clinical Prognostic Determinants Of319Patients Of Advanced Lung Adenocarcinoma
16. Comparison Of The Efficacy Of TKI In Patients Diagnosed With Advanced Lung Adenocarcinoma, Harboring Different EGFR, KRAS Mutation Status
17. Comparition Of Efficacy And Safety Of Pemetrexed、docetaxel Plus Cisplation As First-line Chemotherapy For Advanced Lung Adenocarcinoma
18. Role Of EGFR Mutation Status In Patients With Advanced Lung Adenocarcinoma Treated With Pemetrexed
19. Analysis Of Prognosis In Patients With Advanced Lung Adenocarcinoma
20. Comparison Of Detecting EGFR Mutation Among Different Small Samples Of Advanced Lung Adenocarcinoma By Using ARMS Method
  <<First  <Prev  Next>  Last>>  Jump to